Page 77 - JCTR-11-4

Journal of Clinical and
Translational Research Adherence and psoriasis severity in Brazil

2. Romiti R, Amone M, Menter A, Miot HA. Prevalence of Prefer Adherence. 2019;13:2029-2038.
psoriasis in Brazil - a geographical survey. Int J Dermatol. doi: 10.2147/PPA.S230921
2017;56(8):e167-e168.
13. Feldman SR, Cline A, Pona A, Kolli SS. Treatment
doi: 10.1111/ijd.13604
Adherence in Dermatology. Berlin: Springer International
3. Parisi R, Symmons DP, Griffiths CE, et al. Global Publishing; 2019.
epidemiology of psoriasis: A systematic review of incidence 14. Wang Q, Luo Y, Lv C, et al. Nonadherence to treatment
and prevalence. J Invest Dermatol. 2013;133(2):377-385.
and patient-reported outcomes of psoriasis during the
doi: 10.1038/jid.2012.339 COVID-19 epidemic: A web-based survey. Patient Prefer
Adherence. 2020;14:1403-1409.
4. Parisi R, Iskandar IYK, Kontopantelis E, et al. National,
regional, and worldwide epidemiology of psoriasis: doi: 10.2147/PPA.S263843
Systematic analysis and modelling study. BMJ. 15. Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T.
2020;369:m1590.
How good are clinical severity and outcome measures for
doi: 10.1136/bmj.m1590 psoriasis?: Quantitative evaluation in a systematic review.
J Invest Dermatol. 2010;130(4):933-943.
5. Romiti R, Carvalho AVE, Duarte GV. Consenso brasileiro
de psoríase 2020 e algoritmo de tratamento da sociedade doi: 10.1038/jid.2009.391
brasileira de dermatologia. An Brasil Dermatol (Portuguese). 16. Mucherino S, Rafaniello C, Serino M, et al. Drug utilization
2021;96(6):778-781.
and measurement of medication adherence: A real world
doi: 10.1016/j.abdp.2021.09.013 study of psoriasis in Italy. Pharmaceutics. 2023;15(12):2647.
6. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. doi: 10.3390/pharmaceutics15122647
Psoriasis. Lancet. 2021;397(10281):1301-1315.
17. Aoki KC, Wong S, Duong JQ, Feldman SR. Adherence to
doi: 10.1016/S0140-6736(20)32549-6 psoriasis therapies. Dermatol Clin. 2024;42(3):495-506.
7. Campione E, Mazzilli S, Di Prete M, et al. The role of doi: 10.1016/j.det.2024.02.010
glutathione-S transferase in psoriasis and associated 18. Sá Justo KC, FIlho AB, Zonzini FHT, Dagostini JS, Faria
comorbidities and the effect of dimethyl fumarate in this AR, Tanaka AA, et al. Prevalence of comorbidities in
pathway. Front Med (Lausanne). 2022;9:760852.
patients with psoriasis in Brazil: Preliminary results of the
doi: 10.3389/fmed.2022.760852 pharmacoepidemiological study Pso. BRA. Int J Phys Med
Rehabil. 2022;10(6):653.
8. Silva MF, Fortes MR, Miot LD, Marques SA. Psoriasis:
Correlation between severity index (PASI) and quality of life doi: 10.35248/2329-9096.22.10.653
index (DLQI) in patients assessed before and after systemic 19. Morisky DE, Green LW, Levine DM. Concurrent and
treatment. An Bras Dermatol. 2013;88(5):760-763.
predictive validity of a self-reported measure of medication
doi: 10.1590/abd1806-4841.20132052 adherence. Med Care. 1986;24(1):67-74.
9. Svoboda SA, Ghamrawi RI, Owusu DA, Feldman SR. doi: 10.1097/00005650-198601000-00007
Treatment goals in psoriasis: Which outcomes matter most? 20. Finlay AY, Khan GK. Dermatology life quality index
Am J Clin Dermatol. 2020;21(4):505-511.
(DLQI)--a simple practical measure for routine clinical use.
doi: 10.1007/s40257-020-00521-3 Clin Exp Dermatol. 1994;19(3):210-216.
10. Murage MJ, Tongbram V, Feldman SR, et al. doi: 10.1111/j.1365-2230.1994.tb01167.x
Medication adherence and persistence in patients with 21. Souza AF, Silva MRD, Santos JBD, Almeida AM, Acurcio FA,
rheumatoid arthritis, psoriasis, and psoriatic arthritis: Alvares-Teodoro J. Medication adherence and persistence of
A systematic literature review. Patient Prefer Adherence. psoriatic arthritis patients treated with biological therapy in
2018;12:1483-1503.
a specialty pharmacy in Brazil: A prospective observational
doi: 10.2147/PPA.S167508 study. Pharm Pract (Granada). 2021;19(2):2312.
11. Stein Gold LF. Topical therapies for psoriasis: Improving doi: 10.18549/PharmPract.2021.2.2312
management strategies and patient adherence. Semin Cutan 22. Martins GA, Arruda L, Mugnaini ASB. Validação de
Med Surg. 2016;35(2 Suppl 2):S36-S44; quiz S45.
questionários de avaliação da qualidade de vida em pacientes
doi: 10.12788/j.sder.2016.006 de psoríase. An Brasil Dermatol. 2004;79:521-535.
12. Alsubeeh NA, Alsharafi AA, Ahamed SS, Alajlan A. Treatment 23. Avazeh Y, Rezaei S, Bastani P, Mehralian G. Health literacy
adherence among patients with five dermatological diseases and medication adherence in psoriasis patients: A survey in
and four treatment types - a cross-sectional study. Patient Iran. BMC Prim Care. 2022;23(1):113.

Volume 11 Issue 4 (2025) 71 doi: 10.36922/jctr.24.00057